Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Clague

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Alcoholism, Clinical and Experimental Research|December 1, 1989
Differences in the nature and kinetics of the ethanol-related circulating cytotoxic proteins in normal subjects and patients with alcohol-induced cirrhosisS N Wickramasinghe, J R Clague, I G Barrison, et al.
International Journal of Cardiology|April 12, 2005
Chronic heart failure patients with restrictive LV filling pattern have significantly less benefit from cardiac resynchronization therapy than patients with late LV filling patternTushar V Salukhe, Darrel P Francis, Jonathan R Clague, et al.
The Journal of Rheumatology|June 1, 1985
Genetic variants of properdin factor B (Bf) in rheumatoid arthritisP Dyer, D M Grennan, W Dodds, et al.
The American Journal of Cardiology|April 26, 2006
Mechanism of cardiac output gain from cardiac resynchronization therapy in patients with coronary artery disease or idiopathic dilated cardiomyopathyTushar V Salukhe, Darrel P Francis, Michelle Morgan, et al.
Clinical Science (London, England : 1979)|May 20, 2009
C-type natriuretic peptide production by the human kidney is blunted in chronic heart failurePaul R Kalra, Jonathan R Clague, Andrew J Coats, et al.
Heart (British Cardiac Society)|October 16, 2004
Reduction in plasma concentrations of N terminal pro B type natriuretic peptide following percutaneous coronary interventionP R Kalra, A Gomma, C Daly, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1976
Thyroid-stimulating immunoglobulins and the control of thyroid functionR Clague, E D Mukhtar, G A Pyle, et al.
Heart (British Cardiac Society)|November 7, 2006
Instantaneous effects of resynchronisation therapy on exercise performance in heart failure patients: the mechanistic role and predictive power of total isovolumic timeT V Salukhe, K Dimopoulos, R Sutton, et al.
Circulation|February 5, 2003
Myocardial production of C-type natriuretic peptide in chronic heart failurePaul R Kalra, Jonathon R Clague, Aidan P Bolger, et al.
International Journal of Cardiology|June 15, 2004
Automated quantitation of peripheral blood neutrophil activation in patients with myocardial ischaemiaM J Leckie, A H Gomma, I F Purcell, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Alcoholism, Clinical and Experimental Research|December 1, 1989
Differences in the nature and kinetics of the ethanol-related circulating cytotoxic proteins in normal subjects and patients with alcohol-induced cirrhosisS N Wickramasinghe, J R Clague, I G Barrison, et al.
International Journal of Cardiology|April 12, 2005
Chronic heart failure patients with restrictive LV filling pattern have significantly less benefit from cardiac resynchronization therapy than patients with late LV filling patternTushar V Salukhe, Darrel P Francis, Jonathan R Clague, et al.
The Journal of Rheumatology|June 1, 1985
Genetic variants of properdin factor B (Bf) in rheumatoid arthritisP Dyer, D M Grennan, W Dodds, et al.
The American Journal of Cardiology|April 26, 2006
Mechanism of cardiac output gain from cardiac resynchronization therapy in patients with coronary artery disease or idiopathic dilated cardiomyopathyTushar V Salukhe, Darrel P Francis, Michelle Morgan, et al.
Clinical Science (London, England : 1979)|May 20, 2009
C-type natriuretic peptide production by the human kidney is blunted in chronic heart failurePaul R Kalra, Jonathan R Clague, Andrew J Coats, et al.
Heart (British Cardiac Society)|October 16, 2004
Reduction in plasma concentrations of N terminal pro B type natriuretic peptide following percutaneous coronary interventionP R Kalra, A Gomma, C Daly, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1976
Thyroid-stimulating immunoglobulins and the control of thyroid functionR Clague, E D Mukhtar, G A Pyle, et al.
Heart (British Cardiac Society)|November 7, 2006
Instantaneous effects of resynchronisation therapy on exercise performance in heart failure patients: the mechanistic role and predictive power of total isovolumic timeT V Salukhe, K Dimopoulos, R Sutton, et al.
Circulation|February 5, 2003
Myocardial production of C-type natriuretic peptide in chronic heart failurePaul R Kalra, Jonathon R Clague, Aidan P Bolger, et al.
International Journal of Cardiology|June 15, 2004
Automated quantitation of peripheral blood neutrophil activation in patients with myocardial ischaemiaM J Leckie, A H Gomma, I F Purcell, et al.
Pageof 5